EICHOR
● Completed
Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
Condition: Pediatric Heart Transplantation · Immunosuppression · Chronic Kidney Diseases · Sponsor: Boston Children's Hospital
About this study
The TEAMMATE Trial will enroll 210 pediatric heart transplant patients from 25 centers at 6 months post-transplant and follow each patient for 2.5 years. Half of the participants will receive everolimus and low-dose tacrolimus and the other half will receive tacrolimus and mycophenolate mofetil. The trial will determine which treatment is better at reducing the cumulative risk of coronary artery vasculopathy, chronic kidney disease and biopsy proven-acute cellular rejection without an increase in graft loss due to all causes (e.g. infection, PTLD, antibody mediated rejection).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (25)
| Children's of Alabama | Birmingham, Alabama, United States | — |
| Phoenix Children's Hospital | Phoenix, Arizona, United States | — |
| Loma Linda University | Loma Linda, California, United States | — |
| Children's Hospital Los Angeles | Los Angeles, California, United States | — |
| UCLA Mattel Children's Hospital | Los Angeles, California, United States | — |
| Stanford University | Palo Alto, California, United States | — |
| Children's Hospital Colorado | Aurora, Colorado, United States | — |
| Children's National Medical Center | Washington D.C., District of Columbia, United States | — |
| University of Florida Congenital Heart Center | Gainesville, Florida, United States | — |
| Joe DiMaggio Children's Hospital | Hollywood, Florida, United States | — |
| Children's Healthcare of Atlanta Emory | Atlanta, Georgia, United States | — |
| Lurie Children's Hospital | Chicago, Illinois, United States | — |
+ 13 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03386539